1Parkin D M.Global cancer statistics in the year 2000[J].Lancet Oncol,2001,2(9):533-543.
2Wilmink A B.Overview of epidemiology of colorectal cancer[J].Dis Colon Rectum,1997,40 (4):483-493.
3Scholefield J H,Moss S,Sufi F,et al.Effect of faecal occult blood screening on mortality from colorectal cancer:results from a randomised controlled trial[J].Gut,2002,50 (6):840-844.
4Marcella S,Miller J E.Racial differences in colorectal cancer mortality.The importance of stage and socioeconomic status[J].J Clin Epidemiol,2001,54(4):359-366.
5Allison J E.The effect of fecal occult blood screening on the incidence of colorectal cancer[J].N Engl J Med,2001,344(13):1022-1023.
7Reasbeck P G.Colorectal cancer:the case for endoscopic screening[J].Br J Surg,1987,74(1):12-17.
8Roberts P J.Tumour markers in colorectal cancer[J].Scand J Gastroenterol Suppl,1988 (149):50-58.
9Kozwich D L,Kramer L C,Mielicki W P,et al.Application of cancer procoagulant as an early detection tumor marker[J].Cancer,1994,74 (4):1367-1376.
10Imperiale T F,Ransohoff D F,Itzkowitz S H,et al.Fecal DNA versus fecal occult blood for colorectal cancer screening in an average risk population[J].N Engl J Med,2004,351 (26):2704-2714.
